MCL1/BCLxL ratios, which have previously been described to predict sensitivity to MCL1 inhibitors (33) were also paradoxically lower in PBRM1 mutant ccRCC cells compared to WT (Supplementary Figure S2B). The gene discussed is BCL2L1; the disease is nonpapillary renal cell carcinoma.